Abstract
Discovery and characterization of an apicomplexan Fab I gene and encoded enzyme and discovery of the triclosan as a lead compound, provide means to rationally design novel inhibitory compositions useful for prevention and treatment of apicomplexan related diseases.
Original language | English |
---|---|
Patent number | US 20040137446 A1 |
Priority date | 21/12/00 |
Publication status | Published - 15 Jul 2004 |
Keywords
- enzyme
- inhibitor
- apicomplexan infections